Catalog Home Page

Modification of pre-mRNA processing: Application to dystrophin expression

Wilton, S.D. and Fletcher, S. (2006) Modification of pre-mRNA processing: Application to dystrophin expression. Current Opinion in Molecular Therapeutics, 8 (2). pp. 130-135.

Abstract

Antisense oligonucleotides are emerging as exciting therapeutic agents with the potential to overcome disease-causing mutations in the dystrophin gene. The size and complexity of the dystrophin gene allows for intervention during pre-mRNA processing, where selected exon excision can remove nonsense mutations or restore the reading frame disrupted by genomic deletions or duplications. This review summarizes some of the events leading up to forthcoming clinical trials in 2006, and speculates on some of the challenges facing targeted exon skipping as a therapy for Duchenne muscular dystrophy.

Publication Type: Journal Article
Publisher: Current Drugs Ltd
URI: http://researchrepository.murdoch.edu.au/id/eprint/21558
Item Control Page Item Control Page